Tuesday, May 23, 2023 12pm
About this Event
If your organization is a Research!America alliance member, join us on Tuesday, May 23rd at 12:00 p.m. Eastern for a conversation with Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research (CBER) at FDA. We’ve asked Dr. Marks to discuss efforts to shape a robust, cost- and time-efficient regulatory review pathway for advances in gene therapy. Offering unimagined hope for the treatment and cure of rare childhood diseases and other treatment-elusive health threats, gene therapy is one of the most promising, and challenging, areas of focus for 21st century science. Email Jacqueline Lagoy at JLagoy@researchamerica.org for a registration link to this members-only alliance discussion.
0 people are interested in this event